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ABSTRACT
Objective Postoperative ileus (POi), the most frequent 
complication after intestinal surgery, depends on 
dendritic cells (Dcs) and macrophages. Here, we have 
investigated the mechanism that activates these cells 
and the contribution of the intestinal microbiota for POi 
induction.
Design POi was induced by manipulating the intestine 
of mice, which selectively lack Dcs, monocytes or 
macrophages. the disease severity in the small and large 
intestine was analysed by determining the distribution of 
orally applied fluorescein isothiocyanate-dextran and by 
measuring the excretion time of a retrogradely inserted 
glass ball. the impact of the microbiota on intestinal 
peristalsis was evaluated after oral antibiotic treatment.
Results We found that Cd11c-Cre+ Irf4flox/flox mice 
lack cD103+cD11b+ Dcs, a Dc subset unique to the 
intestine whose function is poorly understood. their 
absence in the intestinal muscularis reduced pathogenic 
inducible nitric oxide synthase (inOS) production by 
monocytes and macrophages and ameliorated POi. 
Pathogenic inOS was produced in the jejunum by 
resident ly6c– macrophages and infiltrating chemokine 
receptor 2-dependent ly6c+ monocytes, but in the colon 
only by the latter demonstrating differential tolerance 
mechanisms along the intestinal tract. consistently, 
depletion of both cell subsets reduced small intestinal 
POi, whereas the depletion of ly6c+ monocytes alone 
was sufficient to prevent large intestinal POi. the 
differential role of monocytes and macrophages in small 
and large intestinal POi suggested a potential role of 
the intestinal microbiota. indeed, antibiotic treatment 
reduced inOS levels and ameliorated POi.
Conclusions Our findings reveal that cD103+cD11b+ 
Dcs and the intestinal microbiome are a prerequisite for 
the activation of intestinal monocytes and macrophages 
and for dysregulating intestinal motility in POi.
INTRODuCTION
Intestinal phagocytes, such as macrophages 
and dendritic cells (DCs), are crucial in main-
taining gut homeostasis1–3 and in regulating intes-
tinal motility.4–7 Under homeostasis, exposure to 
the luminal microbiota does not induce proinflam-
matory responses,5 because these cells possess a 
tolerogenic signature.8 However, such conditioning 
is impaired in acute inflammation, so that these cells 
acquire a proinflammatory signature and induce 
intestinal diseases.4 8–11 The most frequent adverse 
condition after intestinal surgery, postoperative 
ileus (POI), critically depends on the activation of 
intestinal phagocytes, such as macrophages and 
DCs.4 9 12 We have previously shown in a murine 
model of POI that surgical injury to the intestinal 
tract caused intestinal DCs to locally produce the 
proinflammatory mediator interleukin-12 (IL-12), 
which stimulated memory Th1 cells to produce 
interferon-γ (IFNγ), which in turn activated macro-
phages to express inducible nitric oxide synthase 
(iNOS). Its product NO paralyses intestinal muscle 
cells, resulting in POI.4 9 12 These findings estab-
lished the molecular cascade linking intestinal DCs 
Significance of this study
What is already known on this subject?
 ► Postoperative ileus (POI) is the most frequent 
complication after intestinal surgery.
 ► The accumulation of dendritic cells and 
macrophages has been observed in POI.
 ► Intestinal macrophages produce inducible nitric 
oxide synthase (iNOS) that impairs intestinal 
peristalsis in POI.
What are the new findings?
 ► Intestinal muscularis CD103+CD11b+ DCs 
depend on the transcription factor Irf4 and 
initiate POI by stimulating iNOS production in 
monocytes and macrophages.
 ► Infiltrating Ly6C+ monocytes and resident Ly6C– 
macrophages produce iNOS and cause small 
intestinal POI, whereas only Ly6C+ monocytes 
induce large intestinal POI.
 ► Antibiotic treatment reduces iNOS and 
ameliorates POI.
How might it impact on clinical practice in the 
foreseeable future?
 ► Modulating the intestinal microbiota may be a 
prophylactic strategy against POI.
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that sense local injury and intestinal macrophages that stop peri-
stalsis. However, the identity of the relevant DCs and macro-
phages, their individual roles in regulating intestinal peristalsis 
in POI and the signals that regulate their local activation are 
unclear.
Intestinal macrophages and DCs express an overlapping 
pattern of surface molecules, which often hampers definitive 
conclusions concerning their specific functions. Intestinal DCs 
are defined by the expression of CD11c, CD103, major histo-
compatibility complex (MHC) class II and differential expression 
of CD11b.13 CD103+CD11b– DCs depend on the transcrip-
tion factors Batf3 and Irf8.14 15 They cross-present antigen to 
CD8+ T cells,16 induce regulatory T cells and modulate T cell 
responses.13 DCs expressing CD11b and CD103 develop from 
the common Flt3L-dependent pre-cDC progenitor17 18 by mech-
anisms involving the transcription factors Irf4.19 They are unique 
to the intestinal tract and have been shown to contribute to intes-
tinal immunity.18 20 21 However, their role in intestinal disease is 
much less understood than that of the other phagocyte subsets.
In contrast to DCs, monocytes and macrophages in the 
intestine lack CD103 expression and are defined by expres-
sion of F4/80, CX3CR1 and CD64.
13 22 These cells are further 
subdivided by Ly6C into Ly6C–CX3CR1
high macrophages and 
Ly6C+CX3CR1
low monocytes, which originate from recently 
recruited Ly6C+ blood monocytes. Some resident Ly6C– macro-
phages in the liver, the brain and the skin are long-living cells, 
which are derived from earlier yolk sac and fetal liver progen-
itors.23–25 They can maintain themselves during life with little 
contribution of circulating Ly6C+ monocytes.25 26 However, 
intestinal Ly6C– macrophages have an exceptionally short half-
life of 3 weeks27 and are constantly replaced by blood-derived 
Ly6C+ monocytes.17 18 28 29 Hence, the majority of intestinal 
monocytes and macrophages represents a continuum of differen-
tiation with an important role in intestinal homeostasis by regu-
lating different functional capabilities in health and disease.7 30 
In the present study, we have investigated the different phago-
cyte subsets in the small and large intestine and their role in POI.
ReSulTS
CD103+CD11b+ DCs in the intestinal muscularis depend on 
Irf4 and are crucial for POI
We have previously shown that intestinal CD103+CD11b+ DCs 
produced IL-12 in POI, which stimulated IFNγ production by 
pathogenic memory Th1 cells.4 To determine the necessity of this 
DC subset for POI, we used Cd11c-Cre+ Irf4flox/flox (Cd11c-Cre+) 
mice, which have been reported to lack these cells in the mesen-
teric lymph nodes and partially in the lamina propria.19 We first 
established that these DCs were also absent from the intestinal 
muscularis after small intestinal manipulation (SIM) (figure 1A, 
online supplementary figure 1), whereas the minor population of 
CD103+CD11b– DCs was unchanged (figure 1B). Importantly, 
both small (figure 1C,D) and large intestinal POI (figure 1E) 
were reduced in the absence of CD103+CD11b+ DCs, identi-
fying these DCs as critical inducers of POI.
CD103+CD11b+ DCs regulate iNOS expression by small 
intestinal monocytes and macrophages
The expression of iNOS by intestinal macrophages medi-
ates POI by paralysing intestinal myocytes.4 31 To investigate 
whether CD103+CD11b+ DCs regulate iNOS production, we 
first enumerated CD64+F4/80+ cells in the muscularis. We 
found a strong increase of these cells after SIM, suggesting that 
some of these cells might originate from recruited monocytes 
(figure 1F,G). Such increase was not reduced in Cd11c-Cre+ 
mice, which lack CD103+CD11b+ DCs (figure 1G). Therefore, 
we hypothesised that CD64+F4/80+ cells were unable to produce 
pathogenic iNOS. Indeed, iNOS expression by CD64+F4/80+ 
cells was significantly increased after SIM only in Cd11c-Cre– 
littermates, but not in Cd11c-Cre+ mice (figure 1H). These data 
indicate that Irf4-dependent CD103+CD11b+ DCs locally acti-
vate muscularis monocytes and macrophages to produce iNOS.
Increase of ly6C+ monocytes in the manipulated small 
intestine depends on chemokine receptor 2 (CCR2)
Distinct monocytes and macrophages differing in Ly6C and 
CX3CR1 expression have been described in the circulation and 
in the intestine.8 32 33 We asked whether iNOS-producing mono-
cytes or macrophages mediated POI in the intestinal muscu-
laris. The small intestinal muscularis of sham-manipulated mice 
mainly harboured Ly6C–CX3CR1
high macrophages (figure 2A). 
SIM induced a significant increase of cells expressing high 
levels of Ly6C, but low levels of CX3CR1 (Ly6C
+CX3CR1
low) 
(figure 2A). These cells expressed low levels of MHC class II on 
their surface (figure 2B), suggesting that these cells originated 
from recruited Ly6C+blood monocytes. Notably, all CX3CR1
low 
cells expressed CD64 (online supplementary figure 2, middle 
histogram), indicating that the recently described lamina propria 
CD64–CD103–CX3CR1
low DCs20 21 are not present in the manip-
ulated muscularis. Given that CCR2 is crucial for the abundance 
of Ly6C+ blood monocytes, the direct progenitor of Ly6C+ 
monocytes in the muscularis,32 we hypothesised that CCR2 
mediates the increase of these cells in POI. To facilitate detection 
of Ly6C+CX3CR1
low monocytes also in mice lacking CCR2, we 
generated Ccr2–/– Cx3cr1
GFP mice. We found that the abundance 
of Ly6C+ monocytes but not of Ly6C– macrophages was severely 
decreased after SIM of Ccr2–/– Cx3cr1
GFP mice (figure 2C). These 
data demonstrate that the increased abundance of Ly6C+ mono-
cytes within the manipulated muscularis depends on the recruit-
ment of CCR2-dependent Ly6C+blood monocytes.
ly6C– macrophages and ly6C+ monocytes are both sufficient 
to induce small intestinal POI
We next asked whether Ly6C+ monocytes and/or Ly6C– macro-
phages produced pathogenic iNOS in POI. We first examined 
the progenitors of Ly6C+ muscularis monocytes, namely Ly6C+ 
blood monocytes. However, we were unable to detect iNOS 
expression in blood monocytes of manipulated or sham-oper-
ated mice (figure 2D). In contrast, Ly6C+ monocytes as well 
as Ly6C– macrophages within the small intestinal muscularis 
upregulated iNOS after SIM, indicating their local activation 
(figure 2D).
Next, we analysed the requirement of these iNOS-producing 
Ly6C– macrophages and Ly6C+ monocytes for POI by selective 
targeting. To target Ly6C+ monocytes, we again employed Ccr2–
/– mice and found that these mice were not protected from small 
intestinal POI (figure 3A,B). To confirm these data, we condi-
tionally depleted Ly6C+ monocytes by clodronate liposomes. 
We found a strong reduction of Ly6C+ monocytes, whereas the 
number of Ly6C– macrophages and CD103+CD11b+ DCs was 
not reduced at various time points after depletion (figure 3C,D, 
online supplementary figure 3). However, depletion of Ly6C+ 
monocytes did not reduce POI (figure 3E), confirming the find-
ings in CCR2-deficient animals (figure 3A,B).
Next, we hypothesised that iNOS by Ly6C– macrophages are 
crucial for POI induction. As these cells are targeted neither 
by CCR2 nor clodronate (figures 2C and 3D), we employed 
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Cx3cr1-Cre
+ iDtrflox/+ mice based on their high CX3CR1 expres-
sion. In contrast to Ly6C–CX3CR1
high macrophages in the intes-
tine, this macrophage subset in other organs, such as microglia 
in the central nervous system (CNS), are radioresistant.24 To 
avoid depletion of these radioresistant microglia in the CNS, we 
generated bone marrow chimeric mice to avoid neurological side 
effects by the depletion of microglia in the CNS. Hence, C57BL/6 
recipient mice were engrafted with bone marrow of Cx3cr1-Cre
+ 
iDtrflox/+ mice. We found a reduction of Ly6C– macrophages 
within the muscularis after administration of diphtheria toxin 
(DT) into Cx3cr1-Cre
+ iDtrflox/+ mice (BM-iDTR) (figure 4A), 
whereas the number of Ly6C+ monocytes in the muscularis 
Figure 1 Postoperative ileus depends on Irf4-dependent CD103+CD11b+ DCs. (A,B) The number of CD103+CD11b+ (A) and CD103+CD11b– DCs (B), 
pregated on Hoechst–CD45+CD11c+MHCII+ cells, were determined by flow cytometric analysis 24 hours after small intestinal manipulation (SIM) or 
sham manipulation in Cd11c-Cre– Irf4flox/flox (Cd11c-Cre–) and Cd11c-Cre+ Irf4flox/flox (Cd11c-Cre+) mice (representative data of SIM n=8, sham n=5). 
(C–E) Analysis of small intestinal (C–D) and large intestinal motility (E) in Cd11c-Cre+ or Cd11c-Cre– mice 24 hours after SIM (FITC-Dex=Fluorescein 
isothiocyanate-dextran, S=stomach, 1–10=small intestinal segments, Z=caecum, C1-3=large intestinal segments) (SIM n=8, sham n=4). (F) 
Gating scheme for macrophages in Cd11c-Cre– mice 24 hours after intestinal manipulation. (G) The number of muscularis macrophages (Hoechst–
CD45+F4/80+CD64+) in Cd11c-Cre+ or Cd11c-Cre− mice was determined 24 hours after SIM or sham manipulation by flow cytometry (representative 
data of SIM n=8, sham n=5). (H) CD64+F4/80+ macrophages were isolated by cell sorting 24 hours after SIM or sham. Nos2 (inducible nitric oxide 
synthase) expression was determined by quantitative PCR and the expression was normalised to Hprt (HPRT) (nd=non-detectable) (n=8 SIM, 
n=4 sham). Results are given as mean +/-SEM. *p<0.05; **p<0.01;***p<0.001.
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was not changed (figure 4B). Notably, we found a slight reduc-
tion of Ly6C+ blood monocytes and of CD103+CD11b+ DCs 
(figure 4C and online supplementary figure 3). However, 
depleting Ly6C– macrophages in BM-iDTR mice did not amelio-
rate small intestinal POI (figure 4D,E). Hence, we speculated 
that the lack of Ly6C– macrophages might be compensated by 
Ly6C+ monocytes and vice versa. We therefore combined the 
depletion of Ly6C– macrophages in chimeric BM-iDTR mice 
with the conditional depletion of Ly6C+ monocytes by clodro-
nate liposomes. Indeed, depletion of both Ly6C+ monocytes 
and Ly6C– macrophages markedly reduced POI (figure 4E), 
confirming that these iNOS-producing cells are sufficient to 
induce POI within the small intestine.
Only ly6C+ monocytes induce large intestinal POI
We have shown previously and in figure 1 that small intestinal 
POI can spread to non-manipulated large intestinal segments.4 12 
Hence, we next investigated the role of Ly6C– macrophages and 
Ly6C+ monocytes in inducing colonic POI. We found a profound 
influx of Ly6C+ monocytes into the large intestinal muscularis 
after SIM (figure 5A). Ly6C+ monocytes expressed low levels of 
MHC class II on their surface in comparison to Ly6C– macro-
phages (figure 5B). The increase of Ly6C+ monocytes in the 
colonic muscularis was dependent on CCR2 (figure 5C), 
suggesting that these cells originated from Ly6C+blood mono-
cytes. In contrast, the number of Ly6C– macrophages was unaf-
fected by the lack of this chemokine receptor (figure 5D). To 
investigate the role of Ly6C+ monocytes in inducing large intes-
tinal POI, we employed CCR2-deficient animals. In contrast to 
the small intestine, the selective lack of Ly6C+ monocytes in 
CCR2-deficient animals strongly reduced large intestinal POI 
(figure 5E). Moreover, conditional depletion of Ly6C+ mono-
cytes by clodronate liposomes also reduced POI (online supple-
mentary figure 4A,B). Notably, the number of Ly6C– macrophages 
was not reduced (online supplementary figure 4C). These data 
demonstrate that recruited Ly6C+ monocytes are essential for 
colonic POI, implying that Ly6C– macrophages are dispensable.
ly6C– macrophages in the large intestine are unable to 
express iNOS
Next, we wished to clarify why CCR2 deficiency after SIM 
selectively protected against large intestinal, but not against 
small intestinal POI. We first hypothesised that this discrep-
ancy occurred, because we had manipulated the small intes-
tine, reasoning that this might have provided additional stimuli, 
such as the release of Damage Associated Molecular Patterns 
(DAMPs), which enabled local phagocyte activation in the 
manipulated small intestine, but not in the distant colon. To test 
this hypothesis, we changed the site of manipulation and manip-
ulated the large intestine of CCR2-deficient animals. However, 
the large intestine of CCR2-deficient mice was still protected 
against POI (figure 5F). Consistently, iNOS was only produced 
by large intestinal Ly6C+ monocytes but not by Ly6C– macro-
phages (figure 5G,H). Thus, the site of intestinal manipulation 
did not decide whether Ly6C– macrophages produced iNOS 
and caused POI, implying that other mechanisms prevented 
colonic macrophages from iNOS production. Given that 
Figure 2 The abundance of inducible nitric oxide synthase (iNOS)-producing Ly6C+ monocytes depends on CCR2. (A) Small intestinal muscularis 
monocytes (MOs) and macrophages (MPs), pregated on Hoechst–CD45+F4/80+ cells, were analysed for their expression of CX3CR1 and Ly6C 24 hours 
after small intestinal manipulation (SIM) by flow cytometry. (B) Flow cytometric analysis of major histocompatibility complex (MHC) class II expression 
on Ly6C+CX3CR1
low monocytes (left) and Ly6C–CX3CR1
high macrophages (right), pregated on live/dead–CD45+F4/80+, in the muscularis 24 hours after 
SIM. The solid line represents the MHC class II expression, whereas the grey area indicates control staining (Fluorescence Minus One) (representative 
data of n=6). (C) The number of Ly6C+CX3CR1
low monocytes (left bar graph) and Ly6C–CX3CR1
high macrophages (right bar graph) were determined in 
the muscularis 24 hours after SIM or sham in Cx3cr1
GFP/+ and Cx3cr1
GFP/+ Ccr2−/− mice (representative data of n=8). (D) Ly6C+CX3CR1
low monocytes 
and Ly6C–CX3CR1
high macrophages from the small intestinal muscularis and from the blood were isolated by cell sorting 24 hours after SIM or sham. 
Nos2 (iNOS) expression was determined by quantitative PCR and the expression was normalised to Hprt (HPRT) (representative data of blood n=8, 
muscularis n=8) (nd = not detectable). Results are given as mean +/− SEM. *p<0.05; **p<0.01.
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CD103+CD11b+ DCs initiate iNOS production by macrophages 
(figure 1), we analysed the presence of these cells after manipula-
tion. We found that these cells are absent in the colon (figure 5I), 
suggesting that the presence of CD103+CD11b+ DCs might be 
required for iNOS production by Ly6C– macrophages.
POI depends on the intestinal microbiota
Another difference between the small and large intestine is the 
composition and quantity of the microbiota.34 35 To investigate 
the role of the microbiota for the activation of CD103+CD11b+ 
DCs, monocytes and macrophages, and the induction of POI, 
we depleted the microbiota by antibiotics (online supplementary 
figure 5). We noted a considerable reduction of IL-12 (figure 6A) 
and iNOS (figure 6B), suggesting that the activation of DCs, 
monocytes and macrophages depends on the microbiota. 
Notably, RNA and protein analyses revealed a strong reduction 
of IFNγ (figure 6C,D), suggesting that the previously described 
Th1 response was inhibited.4 We found that mice treated with 
antibiotics showed a moderate reduction in small intestinal 
POI (figure 6E,F). However, antibiotic treatment also reduced 
intestinal peristalsis in sham-operated animals (figure 6F). In 
the colon, POI was strongly reduced after antibiotic treatment 
(figure 6G), demonstrating the essential role of the microbiota 
for POI induction.
DISCuSSION
Macrophages and DCs play central roles in intestinal immu-
nity,13 36 in the regulation of intestinal peristalsis and in POI.4 5 9 
In the present study, we have identified the intestinal microbiota 
and Irf4-dependent CD103+CD11b+ DCs as crucial regulators 
of monocyte and macrophage responses in POI.
Two subsets of intestinal CD103+ DCs with differen-
tial expression of CD11b have been defined previously.37 
CD103+CD11b– DCs depend on the transcription factors Batf3 
and Irf8,14 15 whereas CD103+CD11b+ DCs depend on the tran-
scription factor Irf4.19 38 Consistent with these previous findings, 
Figure 3 Selective depletion of Ly6C+ monocytes does not ameliorate small intestinal POI. (A,B) Measurement of small intestinal motility 24 hours 
after small intestinal manipulation (SIM) or sham manipulation in Ccr2−/− or C57Bl/6 (WT) mice (representative data of SIM, n=8, sham n=5) (FITC-
Dex=Fluorescein isothiocyanate-dextran, S=stomach, 1–10=jejunal segments, Z=caecum, C1-3=colonic segments). (C,D) Flow cytometric analysis of 
Ly6C+CX3CR1
low monocytes (MOs) (C) or Ly6C–CX3CR1
high macrophages (MPs) (D), pregated on Hoechst–CD45+F4/80+ cells, in the small intestine of 
Cx3cr1
GFP/+ mice. Mice were treated with clodronate liposome (CloLip) 12 hours before SIM and the number of cells was analysed 3 and 24 hours after 
SIM and in unmanipulated mice (0 hours) (representative data of n=3–6). (E) One day after SIM, FITC-dextran transit was analysed in CloLip-treated 
C57Bl/6 mice (n=9) (FITC-Dex=fluorescein isothiocyanate-dextran, S=stomach, 1–10=equal small intestinal segments, Z=caecum, C1-3=equal large 
intestinal segments). Results are given as mean +/− SEM. *p<0.05; **p<0.01; ***p<0.001.
group.bmj.com on December 5, 2017 - Published by http://gut.bmj.com/Downloaded from 
2115Pohl J-M, et al. Gut 2017;66:2110–2120. doi:10.1136/gutjnl-2017-313856
Neurogastroenterology
we found that CD103+CD11b+ DCs in the intestinal muscu-
laris depend on Irf4. Lack of these DCs in Cd11c-Cre+ Irf4flox/flox 
mice ameliorated POI and reduced iNOS production by intes-
tinal macrophages. As iNOS expression depended on IFNγ by 
Th1 memory cells,4 Irf4-dependent CD103+CD11b+ DCs may 
be directly involved in the Th1 response and subsequent macro-
phage activation resulting in POI. These findings identify a novel 
role of this enigmatic intestinal DC subset in a disease model.
Macrophages are considered crucial in the regulation of intes-
tinal peristalsis5 and in POI.4 9 In particular, iNOS production by 
these cells has been shown to induce POI by directly inhibiting 
smooth muscle cells.4 9 31 We found a strong CCR2-dependent 
increase of Ly6C+ monocytes in the intestine consistent with 
previous studies in other inflammatory models.8 17 39 These cells 
resemble recruited Ly6C+ blood monocytes, which can locally 
be activated to produce proinflammatory mediators.8 10 40 Also 
in POI, they underwent a functional switch from iNOS-negative 
blood monocytes to iNOS-producing monocytes in the manip-
ulated intestinal muscularis. These data suggest that local toler-
ance mechanisms are disabled in POI. Notably, the expression 
of MHC class II on Ly6C+ monocytes in the small intestine 
exceeded the expression in the colon, which might be due to 
signals derived from the local manipulation of the small intestine.
Targeting Ly6C+ monocytes has been suggested for disease 
management of several inflammatory disorders.10 41 We aimed at 
achieving a beneficial effect in the initial phase after POI induc-
tion by reducing the abundance of recruited iNOS-producing 
Ly6C+ monocytes. However, lack of these cells in CCR2-de-
ficient mice or their conditional depletion through clodronate 
liposomes only ameliorated large intestinal, but not small intes-
tinal POI. These findings do not exclude a role of these cells 
during the resolution phase after POI induction. Further studies 
are required to delineate the role of muscularis macrophages in 
tissue repair.
The finding that depletion of Ly6C+ monocytes did not 
ameliorate small intestinal POI suggested compensatory mech-
anisms. Indeed, we found that Ly6C– macrophages in the small 
intestine were also able to produce iNOS after intestinal manip-
ulation, thereby compensating for the lack of Ly6C+ monocytes. 
In contrast, Ly6C– macrophages in the colon failed to produce 
iNOS, indicating a differential and tolerant functional state. This 
finding was corroborated by recent studies demonstrating that 
Ly6C– macrophages in the colonic intestinal mucosa retain their 
tolerant and non-inflammatory signature even under inflam-
matory conditions.8 10 A plausible mechanism that prevents 
colonic Ly6C– macrophages to produce iNOS is the composi-
tional and quantitative differences between the microbiota in 
the small intestine and the colon.34 35 The constant exposure to 
the abundant colonic microbiota inhibits iNOS production by 
Ly6C– macrophages, in order to avoid inappropriate responses 
against commensals, also in the context of POI. Another expla-
nation is the regional distribution of CD103+CD11b+ DCs along 
the intestine. Consistent with previous findings,42 we found that 
the colonic muscularis hardly harboured CD103+CD11b+ DCs, 
suggesting that their absence in the colonic muscularis might be 
causative for the lack of iNOS expression by Ly6C– macrophages.
To analyse the role of Ly6C– macrophages in small intes-
tinal POI, we designed a conditional deletion approach in 
bone marrow chimeric mice, by reconstituting lethally irra-
diated mice with bone marrow from Cx3cr1-Cre
+ iDtrflox/+ 
mice (BM-iDTR). Application of DT into these mice depleted 
Ly6C– macrophages. Notably, we also found a slight reduction 
of CD103+CD11b+ DCs, which was less pronounced than in 
the transgenic Cd11c-Cre+ Irf4flox/flox mice. The application 
Figure 4 Small intestinal postoperative ileus is induced by Ly6C+ monocytes or Ly6C– macrophages. (A–C) Abundance of Ly6C–F4/80+ macrophages 
(MPs) (A), Ly6C+F4/80+ monocytes (B) and Ly6C+CD115+ monocytes (C) after sham (A) or small intestinal manipulation (SIM) in the small intestinal 
muscularis (B) or in the blood (C) of Cx3cr1-Cre
+ iDtrflox/+ (BM-iDTR) or C57Bl/6 (BM-WT) bone marrow chimeras treated with diphtheria toxin (+DT) 
or left untreated (–DT) (representative data of n=7). (D,E) Measurement of small intestinal motility 24 hours after SIM or sham in Cx3cr1-Cre
+ iDtrflox/+ 
(BM-iDTR) or C57Bl/6 (BM-WT) mice (SIM n=11, SIM DT and CloLip n=7, sham n=4) (FITC-Dex=Fluorescein isothiocyanate-dextran, S=stomach, 
1–10=small intestinal segments, Z=caecum, C1-3=large intestinal segments). GC=geometric centre; CloLip=clodronate liposomes. Results are given 
as mean +/− SEM. *p<0.05; **p<0.01; ***p<0.001.
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of DT was insufficient to reduce POI, suggesting that both, 
iNOS produced by Ly6C+ monocytes and Ly6C– macrophages, 
might be sufficient to trigger POI. To test for this possibility, 
we combined the DT-dependent deletion of Ly6C– macrophages 
with the conditional deletion of Ly6C+ monocytes by clodronate 
liposomes. And indeed, the loss of both cell subsets attenuated 
POI, verifying compensatory roles of Ly6C– macrophages and 
Ly6C+ monocytes in small intestinal POI.
Figure 5 Large intestinal postoperative ileus depends on Ly6C+ monocytes. (A) Flow cytometric analysis of large intestinal muscularis monocytes 
(MOs) and macrophages (MPs), pregated on Hoechst–CD45+F4/80+ cells, 24 hours after small intestinal manipulation (SIM) in Cx3cr1
GFP/+ mice. (B) 
Flow cytometric analysis of MHC class II expression on Ly6C+CX3CR1
low monocytes (left) and Ly6C–CX3CR1
high macrophages (right), pregated on live/
dead–CD45+F4/80+ cells, in muscularis 24 hours after SIM. The solid line represents the major histocompatibility complex (MHC) class II expression, 
whereas the grey area indicates control staining (Fluorescence Minus One) (representative data of n=6). (C,D) Numerical analysis of Ly6C+ monocytes 
(C) and Ly6C– macrophages (D) in large intestinal muscularis 24 hours after SIM in Cx3cr1
GFP/+ and Ccr2−/− Cx3cr1
GFP/+ mice (representative data of 
n=8). (E) Large intestinal motility in Ccr2−/− and C57Bl/6 (WT) mice 24 hours after SIM (SIM n=26, sham n=5). (F) Large intestinal transit 24 hours 
after sham or large intestinal manipulation (LIM) of Ccr2−/− and C57Bl/6 (WT) mice (LIM n=8, WT LIM n=9, sham n=5). (G,H) Large intestinal 
Ly6C+CX3CR1
low monocytes and Ly6C–CX3CR1
high macrophages, pregated on Hoechst–CD45+F4/80+cells, were isolated from Cx3cr1
GFP/+ mice by cell 
sorting 24 hours after either LIM (G) or SIM (H) and Nos2 (inducible nitric oxide synthase) expression was determined by quantitative-PCR. Expression 
was normalised to Hprt (HPRT) (nd=non-detectable) (representative data of n=8). (I) The number of CD103+CD11b+dendritic cells, pregated on 
Hoechst–CD45+CD11c+MHCII+ cells, were determined by flow cytometric analysis in small and large intestinal muscularis 24 hours after sham or SIM 
(representative data of SIM n=4, sham n=3). Results are given as mean +/− SEM. *p<0.05; **p<0.01.
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We next asked whether iNOS production by monocytes and 
macrophages is regulated by CD103+CD11b+ DCs and by the 
intestinal microbiota. We found that iNOS production by mono-
cytes and macrophages was severely reduced in the absence of 
CD103+CD11b+ DCs. This correlative finding does not indicate 
a direct interaction between these cells, and as described previ-
ously other leucocytes are involved in this signalling cascade.4 
The activation of CD103+CD11b+ DCs and the attenuation of 
POI in the absence of these cells raised the question which mech-
anism activated these DCs. Translocation of microbial products 
Figure 6 Postoperative ileus depends on the intestinal microbiota. (A–D) The small intestinal muscularis of untreated (–Antibiotics) and antibiotic-
treated (+Antibiotics) mice was isolated 24 hours after small intestinal manipulation (SIM). Il12a, Nos2 (iNOS) and Ifng (IFNγ) RNA (A–C) or IFNγ 
protein (D) expression was analysed by quantitative-PCR (A–C) or ELISA (D) (–Antibiotics SIM n=7 (A) n=4 (B–D), +Antibiotics SIM n=8). (E,F) 
Measurement of small intestinal motility 24 hours after SIM or sham manipulation (sham) in antibiotic-treated and untreated mice (–Antibiotics 
sham n=5, –Antibiotics SIM n=18, +Antibiotics sham n=7, +Antibiotics SIM n=22) (FITC-Dex=Fluorescein isothiocyanate-dextran, S=stomach, 
1–10=jejunal segments, Z=caecum, C1-3=colonic segments). (G) The large intestinal motility of antibiotic-treated or untreated mice was measured 
24 hours after SIM or sham manipulation (sham) (–Antibiotics sham n=5, –Antibiotics SIM n=11, +Antibiotics sham n=7, +Antibiotics SIM n=15). 
Results are given as mean +/− SEM. *p<0.05; **p<0.01; ***p<0.001.
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into the intestinal tissue is a well-documented feature in POI43 44 
and MyD88-dependent sensing of microbial products induces 
IL-12 production by DCs.45 46 In support of this hypothesis, POI 
has explicitly been shown to be attenuated in mice lacking Toll-
like receptor signalling,45 a prerequisite for microbial sensing. 
As CD103+CD11b+ DCs abundantly express Toll-like recep-
tors,46 47 sensing the microbiota, for example, by TLR4 or 5 may 
activate these DCs and induce POI. Our results do not prove 
that CD103+CD11b+ DCs directly sense the microbiome. It 
is also possible that another cell senses the microbiome and 
then stimulates CD103+CD11b+ DCs to produce IL-12, the 
mediator that starts the inflammatory cascade leading to POI.4 
Answering this question might be possible with the use of mice 
in which only CD103+CD11b+ DCs lack MyD88. Generating 
these mice would require discovering a promoter specific for 
CD103+CD11b+ DCs.
Our present findings identify novel players in POI and thereby 
open new therapeutic opportunities. While inhibiting patho-
genic players like IL-12 or iNOS might result in immunosup-
pressive side effects, modifying the microbiome in the intestine 
might represent a promising prophylaxis against POI through 
preventing the activation of CD103+CD11b+ DCs. Further 
studies are required to correlate the composition of the micro-
biota with the development of POI. Analysing the composition 
of the microbiota by sequencing the microbiome may indicate 
prognostic markers to identify patients of risk.
In conclusion, our study reveals a novel role of Irf4-dependent 
CD103+CD11b+ DCs in the intestine and differential require-
ments of monocytes and macrophages in the regulation of peri-
stalsis along the gastrointestinal tract. We suggest that modifying 
the microbiome may be a promising prophylaxis against POI, 
as it might avoid inappropriate activation of CD103+CD11b+ 
DCs. Future studies are required to explore the clinical potential 
of this approach.
MATeRIAlS AND MeTHODS
Animals
Mice had been backcrossed >10 generations to C57BL/6 and 
were used at 8–14 weeks of age. Animals were bred and main-
tained under specific pathogen-free (SPF) conditions at the 
animal facilities of the University Clinic of Bonn and Essen.
Generation of bone marrow chimeras
Eight hours after lethal irradiation (9Gy) of 6-week-old 
CD45.1mice, 5*10(6) bone marrow cells were injected into the 
tail vein of recipient animals. Experiments were performed 8 
weeks after bone marrow transfer. Ccr2−/− Cx3cr1
GFP/+ were 
generated by crossing of Ccr2−/−48 with Cx3cr1
GFP/GFP mice.49 
Cd11c-Cre+ Irf4flox/flox mice were kindly provided by William 
Agace19 and bred to Cd11c-Cre– Irf4flox/flox mice. Germline dele-
tion was tested as described previously.19 Cd11c-Cre+ Irf4flox/
flox and Cd11c-Cre– Irf4flox/flox offspring as respective controls 
were used for experiments. Although loss of CD103+CD11b+ 
DCs does not alter commensal microbial communities,50 
Cd11c-Cre+ Irf4flox/flox and Cd11c-Cre– Irf4flox/flox mice were 
cohoused to prevent the development of a different microbiota. 
Bone marrow chimeras were generated by lethally irradiating 
CD45.1 mice and reconstitution with Cx3cr1-Cre
+ iDtrflox/+ bone 
marrow, which was kindly provided by Steffen Jung, Rehovot, 
Israel.
Intestinal manipulation
We performed standardised intestinal manipulation of the 
small or the large intestine as previously described.4 Briefly, 
after isoflurane narcosis, the peritoneal cavity was opened by a 
midline incision, and the jejunum or the colon was placed onto 
sterile moist gauze and manipulated by moist cotton applica-
tors once from the oral to aboral direction. Then, two layers 
of running suture closed the laparotomy. Sham-operated mice 
underwent laparotomy without manipulation.
Functional studies
We measured gastrointestinal fluorescein isothiocya-
nate (FITC)-dextran transit 24 hours after intestinal manipula-
tion. FITC-dextran was applied via gavage into the stomach. 
After 90 min, we sacrificed the animals and divided the gastro-
intestinal tract into 15 pieces (stomach, ten equal parts from 
the jejunum, caecum and three equal parts of the colon) and 
measured the FITC-fluorescence intensity in each intestinal 
segment by fluorometry. We calculated the geometric centre 
of FITC-dextran ((sum (% FITC-fluorescence per segment × 
segment number))/100) and displayed the result as bar graphs. 
The colonic transit measurement was performed 24 hours after 
intestinal manipulation by insertion of a 2 mm glass ball retro-
grade 2.5 cm deep into the colon and measuring the excretion 
time. Additional information on these techniques has been 
reviewed recently.51
Antibiotic treatment
Antibiotic treatment was performed as previously described.5 
Shortly, mice were treated for 1–5 weeks before intestinal 
manipulation with drinking water containing 1 g/L of strepto-
mycin, metronidazole, vancomycin and ampicillin. Water bottles 
were protected from light and drinking solution was exchanged 
every 4 days.
Isolation of intestinal immune cells
We separated the muscularis from the mucosa by slipping 
10 cm length sections from the intestine or colon over a glass rod 
and stripped the muscularis using cotton applicators. We cut the 
muscularis into 5 cm segments and digested these for 45 min at 
37°C with 100 U/mL collagenase type VIII and 50 U/mL DNase 
I in RPMI containing 10% fetal calf serum (FCS) and 0.1% 
sodium azide. Then samples were homogenised by vigorously 
pipetting up and down 10 times using 1000 µL tips; afterwards 
supernatants were passed through a 100 µm nylon mesh.
Flow cytometry
We used the following monoclonal antibody clones: CD103 
(PE, M290, BD); CD45 (APC-Cy7, APC and FITC, 30-F11, 
BD); F4/80 (PE-Cy7, BM8, BioLegend); CD11c (BV421 and 
BV605, N418, BioLegend); CD64 (PE, X54-5/7.1, BioLegend); 
MHC class II (APC and PE-Cy7, M5/114.15.2, BioLegend); 
Ly6C (PerCP-Cy5.5, AL-21, BD); and CD11b (APC and PE, 
M1/70, BD). Unspecific Fc receptor binding was blocked using 
human immune globulin, 10% liquid (Privigen) diluted 1:66. We 
determined absolute cell numbers by adding fixed numbers of 
CaliBRITE APC-beads (6 µm) (BD Biosciences) before measure-
ment as internal reference, excluding dead cells with Hoechst-
33258 (Invitrogen). Additionally, muscularis was weighed before 
digestion and cell numbers were normalised to 100 mg muscu-
laris. Flow cytometry was performed on a BD LSRFortessa II 
(cytometer configuration is listed on https:// cores. ukb. uni- bonn. 
de/ fccf/ wp- content/ uploads/ sites/ 11/ 2017/ 05/ Filter- und- Fluoro-
chrome- Fortessa- BUV. pdf) and data were analysed with Flow-Jo 
software (Tristar). Experiments including fluorescence activated 
cell sorting were performed on a BD Aria with a 70 µm nozzle 
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(configuration: https:// cores. ukb. uni- bonn. de/ fccf/ wp- content/ 
uploads/ sites/ 11/ 2017/ 02/ Filter- und- Fluorochrome- Aria. pdf).
enzyme-linked immunosorbent assay
ELISA on muscularis homogenate was performed as described 
previously.4 Shortly, purified muscularis was homogenised in 
phosphate-buffered saline (PBS) solution containing Roche 
protease inhibitor and supernatant of centrifuged homogenate 
was analysed on either IFNγ or IL-12p70 ELISA (DuoSet, eBio-
science, Heidelberg, Germany).
RNA extraction and real-time PCR
All reagents, if not otherwise specified, were from Applied 
Biosystems. Cells for flow cytometric cell sorting were prepared 
as described above and RNA was extracted using NucleoSpin 
RNA XS kit (Macherey Nagel). Cells were directly sorted into 
the supplied lysis buffer RA1. RNA extraction was performed 
according to the supplier’s instructions. RNA was eluted in 10 µL 
RNAse-free water and directly transcribed into cDNA with the 
High Capacity Reverse Transcription kit according to manufac-
turer’s description. For whole tissue analysis purified muscu-
laris was snap-frozen in liquid nitrogen and extracted using 
NucleoSpin RNA II kit according to manufacturer’s descrip-
tion. High-capacity cDNA kit was used for reverse transcrip-
tion according to manufacturer’s description. Qiagen supplied 
QuantiTect Nos2 primer, primers (5’- TCATTGAATGCTTGGC-
GCTG-3’, 5’-  AGG AACT GGCA AAAG GATGGT-3’) were used 
for Ifnγ, Hprt (5’-  GTC CCAG CGTC GTGA TTAGCGAT-3’, 5’- 
GGG CCAC AATG TGAT GGCCTCC-3’) was used as a standard. 
PCR was performed on a Roche LightCycler using SYBR Green 
Master Mix according to manufacturer’s description. Dissocia-
tion of the PCR products by a melting curve analysis was used 
to exclude samples showing multiple or aberrant melting peaks.
Reagents
Clodronate liposomes were obtained from www. clodronateli-
posomes. org and 200 µL were applied intravenously 12 hours 
before manipulation, at the time point of manipulation and 
6 hours after manipulation if not indicated otherwise. 10 ng DT 
(Sigma Aldrich, Germany) per gram mouse was applied intra-
venously 12 hours before manipulation and at the time point of 
manipulation.
Statistical analysis
Appropriate assumptions of data (eg, normal distribution or 
similar variation between experimental groups) were exam-
ined before statistical tests were conducted. The sample size 
was analysed by G*Power analysis to ensure adequate power to 
detect a prespecified effect size. The number of experiments and 
the amount of mice per group are given in the legends to the 
figures. Student’s t-tests were used whenever two groups were 
compared, and one-way and two-way analyses of variance were 
done wherever necessary to determine significance for all other 
data. In all experiments, statistical significance was determined 
between the groups, which underwent SIM. Results are given as 
mean±SEM; *p<0.05; **p<0.01; ***p<0.001.
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